Herzog Christopher, Zangos Stefan, Zwerner Peter, Costello Philip, Vogl Thomas J, Schoepf U Joseph
Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe-University, Frankfurt, Germany.
J Thorac Imaging. 2007 Feb;22(1):40-8. doi: 10.1097/RTI.0b013e318032394f.
The clinical relevance of coronary artery disease has considerably driven the recent development of radiologic tools for noninvasive cardiac imaging. Modern multidetector row computed tomographic (MDCT) systems combine high temporal and spatial resolution, electrocardiographic synchronization, and ease of use. In cardiac imaging, MDCT has not only replaced electron-beam CT, but also challenges competing methods such as magnetic resonance imaging, echocardiography, or even coronary catheterization. Noncontrast material-enhanced assessment of atherosclerotic plaques (CT calcium scoring) seems useful for the cardiac risk stratification in asymptomatic patients and monitoring of medical (statin) therapy. Contrast material-enhanced CT coronary angiography has become established as a valuable method for several clinical indications such as evaluation of coronary artery anomalies, bypass patency, or preoperative planning. Particularly, the high negative predictive value of a normal CT coronary angiogram allows reliable exclusion of coronary artery stenosis. Plaque characterization is another promising area of research in MDCT cardiac imaging. However, with current technology a reliable distinction between atheroma and fibroatheroma is impaired by restrictions in spatial resolution. Recent studies indicate that CT angiography may also be suited for other clinical applications such as triage of patients with acute coronary syndrome and inconclusive clinical presentation, patients with symptomatic chest pain, and intermediate risk profile or cardiac risk stratification in asymptomatic patients.
冠状动脉疾病的临床相关性极大地推动了用于无创心脏成像的放射学工具的近期发展。现代多排螺旋计算机断层扫描(MDCT)系统结合了高时间和空间分辨率、心电图同步以及易用性。在心脏成像中,MDCT不仅取代了电子束CT,还对诸如磁共振成像、超声心动图甚至冠状动脉导管插入术等竞争方法构成挑战。对动脉粥样硬化斑块进行非对比剂增强评估(CT钙化积分)似乎对无症状患者的心脏风险分层以及药物(他汀类)治疗的监测有用。对比剂增强CT冠状动脉造影已成为一种有价值的方法,适用于多种临床指征,如评估冠状动脉异常、搭桥血管通畅情况或术前规划。特别是,正常CT冠状动脉造影的高阴性预测值能够可靠地排除冠状动脉狭窄。斑块特征分析是MDCT心脏成像中另一个有前景的研究领域。然而,就目前的技术而言,空间分辨率的限制妨碍了对动脉粥样瘤和纤维粥样瘤进行可靠区分。近期研究表明,CT血管造影也可能适用于其他临床应用,如对急性冠状动脉综合征临床表现不明确的患者、有症状性胸痛的患者以及无症状患者的中等风险特征或心脏风险分层进行分诊。